Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state
- PMID: 2118971
Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state
Abstract
Activated macrophages mediate cytotoxicity against tumor targets and thus may modulate development and growth of metastatic tumor cells. Macrophage colony stimulating factor (M-CSF) has a potential role in activating mature macrophages to a cytotoxic state. We employed a murine Kupffer cell (KC) model of cytotoxicity against a tumor necrosis factor (TNF) - sensitive murine colon adenocarcinoma cell line (MCA26) to evaluate the ability of recombinant human M-CSF (rhM-CSF) 1) to act alone as a KC-activating agent and 2) to enhance KC cytotoxicity against MCA26 cells in association with known macrophage activating compounds. rhM-CSF produced a dose-dependent increase in TNF release by KC in vitro with a parallel increase in MCA26 killing. KC activated by rhM-CSF produced less TNF and concomitantly demonstrated a lower cytotoxicity against MCA26 cells when compared with KC activated by gamma interferon (gamma IFN) with or without lipopolysaccharide (LPS). M-CSF did not act in a synergistic fashion with gamma IFN and LPS to increase TNF secretion or cytotoxicity against MCA26 cells. rhM-CSF thus acts as a single agent capable of activating murine KC to a cytotoxic state but does not cooperate with classical priming/triggering signals to achieve KC activation.
Similar articles
-
Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.J Immunol. 1989 Aug 15;143(4):1198-205. J Immunol. 1989. PMID: 2473121
-
Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.J Immunol. 1991 Oct 15;147(8):2816-23. J Immunol. 1991. PMID: 1918995
-
Reduction of macrophage-mediated tumor cytotoxicity by pretreatment with GM-CSF.Behring Inst Mitt. 1988 Aug;(83):274-7. Behring Inst Mitt. 1988. PMID: 3149190
-
Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).Biotechnol Ther. 1991;2(3-4):231-9. Biotechnol Ther. 1991. PMID: 1845128 Review.
-
Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth.Immunobiology. 2005;210(2-4):259-65. doi: 10.1016/j.imbio.2005.05.020. Immunobiology. 2005. PMID: 16164033 Review.
Cited by
-
Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon gamma.Cancer Immunol Immunother. 1994 Sep;39(3):179-84. doi: 10.1007/BF01533384. Cancer Immunol Immunother. 1994. PMID: 7923248 Free PMC article.
-
Production of cytokines and PGE2 and cytotoxicity of stimulated bone marrow macrophages after thermal injury and cytotoxicity of stimulated U-937 macrophages.Inflammation. 1993 Oct;17(5):583-94. doi: 10.1007/BF00914196. Inflammation. 1993. PMID: 8225565
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials